卡维奥林-1促进了质瘤的进展,并维持了它的线粒体抑制抵抗力
Yu'e Liu1, Yi Chen2, Fei Wang3
1Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
卡维奥林1 (CAV1) 在侵袭性质瘤中高度表达,促进瘤生长,转移和对治疗的抗性. 准CAV1为这种致命的大脑癌症提供了一个有希望的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 分子医学是分子医学.
背景情况:
- 质瘤是一种致命的脑癌,由于异质性和免疫抑制微环境等挑战,治疗选择有限.
- 确定新的治疗点和了解质瘤的发病因子对于改善患者的治疗结果至关重要.
- 预后生物标志物对于指导质瘤患者的治疗策略至关重要.
研究的目的:
- 研究脚手架蛋白质caveolin 1 (CAV1) 在质瘤进展中的作用及其作为治疗点的潜力.
- 分析CAV1表达和质瘤特征之间的相关性,包括对氧化酸化抑制剂的耐药性.
主要方法:
- 氧化酸化 (OXPHOS) 抑制敏感和耐药的质瘤细胞系的RNA测序.
- 对RNA测序,全基因组双硫酸盐测序 (WGBS) 数据和公共数据库的全面分析.
- 对CAV1表达与病理过程,免疫透,转移,干性和患者存活率的相关性分析.
主要成果:
- 在OXPHOS耐药性质瘤细胞和质瘤中,CAV1的表达很高,表达更高与整体存活率较差相关.
- CAV1的表达与免疫透,瘤转移和质瘤茎结合有关.
- 在更高阶段的质瘤中观察到较低的CAV1促进物甲基化,高的CAV1表达赋予了对OXPHOS抑制剂的耐药性.
结论:
- 卡维奥林1 (CAV1) 被确定为质瘤进展中的关键基因,影响多种病理过程.
- CAV1促进质瘤的攻击性,转移和治疗耐药性.
- CAV1代表了改善质瘤治疗结果的潜在治疗标.
更多相关视频
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
10:08Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
Published on: February 24, 2021
相关概念视频
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Stabilize Microtubules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitochondrial Membranes
Drugs that Destabilize Microtubules
